BVF Inc
- SEC CIK
- 0001056807
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 67
- No 13F data for Q4 2020
- Portfolio value
- $2.67B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Five Prime Therapeutics Inc33830X104 | COM | 6,338,678 | $238.8M | 9.0% | – | – | – |
| OLMAOlema Pharmaceuticals, Inc. | COM | 6,661,503 | $221.0M | 8.3% | – | – | History |
| MRUSMerus N.V. | COM | 7,285,071 | $152.2M | 5.7% | – | – | History |
| XOMAXOMA Royalty Corp | COM NEW | 3,530,543 | $144.1M | 5.4% | – | – | History |
| RVMDRevolution Medicines, Inc. | COM | 2,943,049 | $135.0M | 5.1% | – | – | History |
| RPTXRepare Therapeutics Inc. | COM | 3,722,398 | $114.2M | 4.3% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 3,959,451 | $102.5M | 3.8% | – | – | History |
| KYMRKymera Therapeutics, Inc. | COM | 2,630,658 | $102.2M | 3.8% | – | – | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,873,147 | $99.3M | 3.7% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 309,599 | $85.3M | 3.2% | – | – | History |
| EPIXESSA Pharma Inc. | COM NEW | 2,908,326 | $84.5M | 3.2% | – | – | History |
| XENEXenon Pharmaceuticals Inc. | COM | 3,481,778 | $62.3M | 2.3% | – | – | History |
| IONSIonis Pharmaceuticals Inc | COM | 1,364,461 | $61.3M | 2.3% | – | – | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,607,969 | $61.3M | 2.3% | – | – | History |
| ACIUAC Immune SA | SHS | 7,504,579 | $57.1M | 2.1% | – | – | History |
| RCUSArcus Biosciences, Inc. | COM | 1,876,122 | $52.7M | 2.0% | – | – | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 8,394,000 | $49.3M | 1.8% | – | – | History |
| KURAKura Oncology, Inc. | COM | 1,635,112 | $46.2M | 1.7% | – | – | History |
| IMAImageneBio, Inc. | COM | 1,599,658 | $45.2M | 1.7% | – | – | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 1,031,070 | $44.7M | 1.7% | – | – | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,049,356 | $43.7M | 1.6% | – | – | History |
| CTMXCytomX Therapeutics, Inc. | COM | 5,576,471 | $43.1M | 1.6% | – | – | History |
| MTEMMolecular Templates, Inc. | COM | 2,864,299 | $36.1M | 1.4% | – | – | History |
| SPROSpero Therapeutics, Inc. | COM | 2,137,978 | $31.5M | 1.2% | – | – | History |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $28.7M | 1.1% | – | – | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,094,174 | $28.6M | 1.1% | – | – | History |
| VSTMVerastem, Inc. | COM | 11,480,994 | $28.4M | 1.1% | – | – | History |
| INFIInfinity Pharmaceuticals, Inc. | COM | 8,383,645 | $27.1M | 1.0% | – | – | History |
| OVIDOvid Therapeutics Inc. | COM | 6,417,551 | $25.8M | 1.0% | – | – | History |
| ANABAnaptysbio, Inc | COM | 1,189,500 | $25.6M | 1.0% | – | – | History |
| FBRXForte Biosciences, Inc. | COM | 718,788 | $24.6M | 0.9% | – | – | History |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $20.7M | 0.8% | – | – | – |
| CTICCti Biopharma Corp | COM | 6,929,690 | $20.2M | 0.8% | – | – | History |
| STROSutro Biopharma, Inc. | COM | 826,825 | $18.8M | 0.7% | – | – | History |
| IMVTImmunovant, Inc. | COM | 1,144,016 | $18.4M | 0.7% | – | – | History |
| CFRXCONTRAFECT Corp | COM NEW | 3,812,300 | $18.3M | 0.7% | – | – | History |
| GRTSGritstone bio, Inc. | COM | 1,861,239 | $17.6M | 0.7% | – | – | History |
| SLNSilence Therapeutics plc | ADS | 666,666 | $15.8M | 0.6% | – | – | History |
| ELTXElicio Therapeutics, Inc. | COM | 875,000 | $15.8M | 0.6% | – | – | History |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,494,582 | $14.1M | 0.5% | – | – | – |
| REPLReplimune Group, Inc. | COM | 461,428 | $14.1M | 0.5% | – | – | History |
| CALACalithera Biosciences, Inc. | COM | 5,566,690 | $13.5M | 0.5% | – | – | History |
| COGTCogent Biosciences, Inc. | COM | 1,532,282 | $13.5M | 0.5% | – | – | History |
| LITSLite Strategy, Inc. | COM NEW | 3,588,155 | $12.3M | 0.5% | – | – | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,113,435 | $11.9M | 0.4% | – | – | History |
| GNCAGenocea Biosciences, Inc. | COM NEW | 4,012,404 | $10.9M | 0.4% | – | – | History |
| RNACCartesian Therapeutics, Inc. | COM | 2,379,986 | $10.8M | 0.4% | – | – | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 1,715,981 | $10.7M | 0.4% | – | – | History |
| CDTXCidara Therapeutics, Inc. | COM | 3,739,704 | $9.95M | 0.4% | – | – | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 3,229,426 | $9.95M | 0.4% | – | – | History |
| XFORX4 Pharmaceuticals, Inc | COM | 1,091,579 | $9.40M | 0.4% | – | – | History |
| BCTG Acquisition Corp05492W103 | COM | 800,000 | $8.90M | 0.3% | – | – | – |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 772,226 | $8.12M | 0.3% | – | – | – |
| VRDNViridian Therapeutics, Inc. | COM | 463,504 | $7.75M | 0.3% | – | – | History |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $7.53M | 0.3% | – | – | History |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $6.17M | 0.2% | – | – | History |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $5.13M | 0.2% | – | – | History |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 500,000 | $5.11M | 0.2% | – | – | – |
| Eucrates Biomedical Acqu CorG3141W114 | UNIT 10/23/2027 | 500,000 | $5.03M | 0.2% | – | – | – |
| 5 01 Acquisition Corp33836P105 | COM CL A | 500,000 | $4.97M | 0.2% | – | – | – |
| Erytech Pharma29604W108 | SPONSORED ADR | 625,000 | $4.47M | 0.2% | – | – | – |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 647,299 | $4.43M | 0.2% | – | – | – |
| SNDXSyndax Pharmaceuticals Inc | COM | 163,524 | $3.66M | 0.1% | – | – | History |
| JYACJiya Acquisition Corp. | COM CL A | 300,000 | $2.95M | 0.1% | – | – | History |
| IVAInventiva S.A. | ADS | 107,000 | $1.57M | 0.1% | – | – | History |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $1.35M | 0.1% | – | – | History |
| SNCEScience 37 Holdings, Inc. | COM | 100,000 | $1.01M | <0.1% | – | – | History |